Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock Series Avoting [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2019	$ 1	$ 500		$ 1,149,719	$ 1,150,220
Balance at the beginning (in shares) at Dec. 31, 2019	2,000	5,001,252
Net loss				(78,377)	(78,377)
Ending balance, value at Mar. 31, 2020	$ 1	$ 500		1,071,342	1,071,843
Balance at the end (in shares) at Mar. 31, 2020	2,000	5,001,252
Beginning balance, value at Dec. 31, 2019	$ 1	$ 500		1,149,719	1,150,220
Balance at the beginning (in shares) at Dec. 31, 2019	2,000	5,001,252
Shares granted to settle previously recorded liability					507,805
Ending balance, value at Jun. 30, 2020	$ 1	$ 510	609,402	1,065,150	1,675,063
Balance at the end (in shares) at Jun. 30, 2020	2,000	5,103,319
Beginning balance, value at Dec. 31, 2019	$ 1	$ 500		1,149,719	1,150,220
Balance at the beginning (in shares) at Dec. 31, 2019	2,000	5,001,252
Ending balance, value at Dec. 31, 2020	$ 1	$ 795	11,973,051	(2,219,091)	9,754,756
Balance at the end (in shares) at Dec. 31, 2020	2,000	7,945,034
Beginning balance, value at Mar. 31, 2020	$ 1	$ 500		1,071,342	1,071,843
Balance at the beginning (in shares) at Mar. 31, 2020	2,000	5,001,252
Net loss				(6,192)	(6,192)
Shares issued to Carmel, Milazzo & Feil LLP		$ 10	507,795		507,805
Shares issued to Carmel, Milazzo & Feil LLP (in shares)		102,067
Stock-based compensation			101,607		101,607
Stock-based compensation (in shares)
Ending balance, value at Jun. 30, 2020	$ 1	$ 510	609,402	1,065,150	1,675,063
Balance at the end (in shares) at Jun. 30, 2020	2,000	5,103,319
Beginning balance, value at Dec. 31, 2020	$ 1	$ 795	11,973,051	(2,219,091)	9,754,756
Balance at the beginning (in shares) at Dec. 31, 2020	2,000	7,945,034
Shares granted to settle previously recorded liability			21,420		21,420
Shares granted to settle previously recorded liability (in shares)		3,000
Warrant liability recognized in connection with initial issuance of November offering (See Note 8)			(135,125)		(135,125)
Exercise of warrants		$ 2	1,155		1,157
Exercise of warrants (in shares)		17,135
Common stock issued for acquisition		$ 137	7,122,363		7,122,500
Common stock issued for acquisition (in shares)		1,375,000
Net loss				(1,032,951)	(1,032,951)
Stock-based compensation		$ 6	210,735		210,741
Stock-based compensation (in shares)		62,500
Ending balance, value at Mar. 31, 2021	$ 1	$ 940	19,193,599	(3,252,042)	15,942,498
Balance at the end (in shares) at Mar. 31, 2021	2,000	9,402,669
Beginning balance, value at Dec. 31, 2020	$ 1	$ 795	11,973,051	(2,219,091)	9,754,756
Balance at the beginning (in shares) at Dec. 31, 2020	2,000	7,945,034
Shares granted to settle previously recorded liability					21,420
Ending balance, value at Jun. 30, 2021	$ 1	$ 942	19,659,197	(5,390,274)	14,269,866
Balance at the end (in shares) at Jun. 30, 2021	2,000	9,415,386
Beginning balance, value at Mar. 31, 2021	$ 1	$ 940	19,193,599	(3,252,042)	15,942,498
Balance at the beginning (in shares) at Mar. 31, 2021	2,000	9,402,669
Exercise of warrants
Exercise of warrants (in shares)		717
Net loss				(2,138,232)	(2,138,232)
Stock-based compensation		$ 2	465,598		465,600
Stock-based compensation (in shares)		12,000
Ending balance, value at Jun. 30, 2021	$ 1	$ 942	$ 19,659,197	$ (5,390,274)	$ 14,269,866
Balance at the end (in shares) at Jun. 30, 2021	2,000	9,415,386